Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myotonic Dystrophy Type-1”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Large-scale testing (Phase 3)UnknownNCT01225614
What this trial is testing

Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive

Who this might be right for
MyopathyMuscular WeaknessRespiratory Insufficiency
Assistance Publique - Hôpitaux de Paris 77
Not applicableNot Yet RecruitingNCT06596850
What this trial is testing

Wheelchair Skills Training for People with ARSACS and DM1

Who this might be right for
Wheelchair MobilityManual Wheelchair Skills TrainingARSACS+1 more
Laval University 20
Not applicableEnrolling By InvitationNCT06101940
What this trial is testing

Phenotype-Genotype Analysis of DM1 Patients in China

Who this might be right for
Myotonic Dystrophy 1
Huashan Hospital 500
Early research (Phase 1)Study completedNCT03959189
What this trial is testing

Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy, Type 1 (DM1)Myotonic Dystrophy
Expansion Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06185764
What this trial is testing

VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Vertex Pharmaceuticals Incorporated 44
Not applicableStudy completedNCT01530841
What this trial is testing

Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy

Who this might be right for
Myopathy
Centre d'Investigation Clinique et Technologique 805 32
Not applicableUnknownNCT02269865
What this trial is testing

Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1
Stanford University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05481879
What this trial is testing

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Dyne Therapeutics 116
Not applicableStudy completedNCT07362316
What this trial is testing

Longitudinal Evaluation of Neuromuscular Involvement in Type 1 Myotonic Dystrophy

Who this might be right for
Steinert Myotonic Dystrophy
Institut de Myologie, France 50
Not applicableUnknownNCT02880735
What this trial is testing

Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy 1Steinert Disease
National Institute of Respiratory Diseases, Mexico 27
Not applicableStudy completedNCT01136330
What this trial is testing

DM1 Heart Registry - DM1 Respiratory Registry

Who this might be right for
Myotonic Dystrophy
Institut de Myologie, France 914
Large-scale testing (Phase 3)Looking for participantsNCT05532813
What this trial is testing

Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)

Who this might be right for
Steinert's DiseaseMyotonic Dystrophy 1Metformin
Assistance Publique - Hôpitaux de Paris 142
Not applicableStudy completedNCT05865483
What this trial is testing

Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)

Who this might be right for
Myotonic Dystrophy 1Dysphagia, Oropharyngeal
University College, London 177
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06926621
What this trial is testing

Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Vertex Pharmaceuticals Incorporated 44
Not applicableLooking for participantsNCT06075693
What this trial is testing

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1
Massachusetts General Hospital 88
Not applicableLooking for participantsNCT06708468
What this trial is testing

Personalized Training for People With Rare Neuromuscular Disorders

Who this might be right for
Neuromuscular Diseases (NMD)Charcot Marie Tooth Disease (CMT)Facioscapulohumeral Muscular Dystrophy+1 more
Oslo University Hospital 120
Not applicableLooking for participantsNCT07505342
What this trial is testing

Remote Assessments and Genetic Determinants of Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)DM1
University of Rochester 1,000
Not applicableStudy completedNCT04052958
What this trial is testing

DM-IMT - Controlled, Randomized, Three-arm Intervention Study on the Safety and Efficacy of Regular Respiratory Muscle Training in Patients With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
LMU Klinikum 45
Testing effectiveness (Phase 2)Study completedNCT01406873
What this trial is testing

Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy
University of Rochester 42
Not applicableStudy completedNCT05006924
What this trial is testing

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Oslo University Hospital 89
Load More Results